Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation
结直肠肿瘤转化中宿主和微环境的综合单细胞图谱
基本信息
- 批准号:10380489
- 负责人:
- 金额:$ 21.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-20 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenocarcinomaAdverse eventAtlasesCancer EtiologyCarcinomaCellsCessation of lifeChemopreventionClinical DataCollectionColonColonoscopyColorectalColorectal AdenomaColorectal CancerCommunicable DiseasesCommunitiesDataData AnalysesData AnalyticsData SetDevelopmentDoctor of PhilosophyEconomicsEcosystemEpidemiologistEpidemiologyEventExcisionFluorescent in Situ HybridizationGastroenterologistGeneticHealthcare SystemsHemorrhageHumanImmunofluorescence ImmunologicImmunologistImmunologyIncidenceIndividualMalignant NeoplasmsMapsMethodologyMicrobial BiofilmsModelingNeoplastic Cell TransformationOperative Surgical ProceduresParticipantPathologistPatientsPerforationPhenotypePolypsPrevention strategyReportingResearchResearch PersonnelSamplingSeminalStandardizationSumSurgeonSystemTissuesUnited StatesUniversitiesWorkadenomaanalytical toolbasecolorectal cancer preventioncost effectiveepidemiologic dataexome sequencinghigh riskhuman tissuemicrobialmicrobiomemolecular phenotypemortalitynovelpersonalized diagnosticspremalignantpreventprogramsprospectiveproteogenomicspsychosocialrepositoryrisk stratificationsingle cell analysissingle-cell RNA sequencingspatial relationshiptumor
项目摘要
PROJECT SUMMARY: Overall Colorectal cancer (CRC) is among the top three most prevalent cancers in
global incidence and mortality. Most of these cancers develop from pre-cancerous adenomas. Colonoscopy is
currently the most effective CRC prevention strategy. However, colonoscopy may fail to prevent carcinoma in
as many as 24% of cases, is less effective at preventing proximal CRCs, is expensive for health care systems
to implement, carries economic and psychosocial burdens for patients, and can be complicated by bleeding,
perforation, and other adverse events. There is an unmet need to develop new preventive strategies and risk
stratification models to address these and other issues. By analysis of whole human tissue, seminal work from
Bert Vogelstein and co-workers demonstrated that CRC develops from an accumulation of genetic events as
tumors evolve from small to large adenomas and, eventually, to cancers. More recently, our group reported the
first comprehensive proteogenomic characterization of CRC, which also was from a bulk analysis of whole
tissue Despite this wealth of data on CRC, we believe that the ability to provide the most effective precision
diagnostics and preventive strategies can only be achieved with single-cell analysis. Through such a single-cell
analysis, we propose to map spatial relationships across the spectrum of normal colon, early polyps, and late
adenomas, including their unique stromal and microbial microenvironments. Aim 1: To construct a pre-cancer
atlas of colorectal adenoma progression that depicts the spatial landscape of the tumor ecosystem, including
the stroma and biofilm-associated microbiome, using single-cell (sc)RNA-seq, whole exome sequencing,
multiplex immunofluorescence (MxIF), and species-specific bacterial fluorescence in situ hybridization (FISH).
Aim 2: To integrate the activities and data from the Biospecimen, Tissue Characterization and Data Analysis
Units for the prospective standardized collection and analysis of colorectal tissue, associated biospecimens,
and related clinical and epidemiological data from 1,800 participants undergoing colonoscopy or surgical
resection. Aim 3: To disseminate the pre-cancer atlas, related biospecimens, primary data sets and analytical
tools to the Human Tumor Atlas Network (HTAN), the broader scientific community, and the lay public. To
accomplish these aims, we have assembled a highly interactive and established team of investigators with
complementary expertise (epidemiologists, gastroenterologists, pathologists, surgeons, systems biologists,
bioinformaticians, cancer biologists, immunologists, and biofilms/infectious disease experts). To further
optimize our novel methodologies for application to the prospectively collected samples from 1,800 atlas
participants, we will leverage our existing large repository of colorectal adenomas and supporting
biospecimens, generated and curated through an ongoing epidemiological project through 3 cycles of the
Vanderbilt GI Special Programs of Research Excellence (SPORE). We are confident that our application, in
toto, is greater than the sum of its parts, and we look forward to robust bi-directional interactions with HTAN.
项目摘要:结直肠癌是全球最常见的三种癌症之一。
全球发病率和死亡率。这些癌症中的大多数都是从癌前腺瘤发展而来的。结肠镜检查是
目前最有效的CRC预防策略。然而,结肠镜检查可能无法预防癌症
高达24%的病例在预防近端癌方面效果较差,对医疗保健系统来说代价高昂
实施,给患者带来经济和心理社会负担,并可能因出血而复杂化,
穿孔等不良事件。开发新的预防战略和风险的需求尚未得到满足
分层模型来解决这些和其他问题。通过对整个人体组织的分析,从
Bert Vogelstein和他的同事们证明了CRC是从如下遗传事件的积累发展而来的
肿瘤从小腺瘤演变为大腺瘤,最终演变为癌症。最近,我们的小组报告了
首次对结直肠癌进行了全面的蛋白质组学鉴定,这也是从整体上分析的
组织尽管有如此丰富的关于CRC的数据,我们相信能够提供最有效的精度
只有通过单细胞分析才能实现诊断和预防策略。通过这样一个单细胞
分析后,我们建议绘制正常结肠、早期息肉和晚期息肉的空间关系图
腺瘤,包括其独特的间质和微生物微环境。目标1:构建一个癌前状态
结直肠腺瘤进展图谱,描绘了肿瘤生态系统的空间景观,包括
基质和生物膜相关微生物组,使用单细胞(SC)RNA-SEQ,整个外显子组测序,
多重免疫荧光(MxIF)和物种特异性细菌荧光原位杂交(FISH)。
目的2:整合生物素、组织定征和数据分析的活动和数据
用于结直肠组织的前瞻性标准化收集和分析的单位、相关生物标本、
以及1800名接受结肠镜检查或外科手术的参与者的相关临床和流行病学数据
切除手术。目标3:传播癌前图谱、相关生物图谱、基本数据集和分析
向人类肿瘤图集网络(Htan)、更广泛的科学界和普通公众提供工具。至
为了实现这些目标,我们组建了一支高度互动和成熟的调查团队,
互补专业知识(流行病学家、胃肠病学家、病理学家、外科医生、系统生物学家、
生物信息学家、癌症生物学家、免疫学家和生物膜/传染病专家)。为了进一步
优化我们的新方法,以应用于从1,800份地图集中预期收集的样本
参与者,我们将利用我们现有的大型结直肠腺瘤存储库和支持
生物检疫,通过一个持续的流行病学项目产生和管理,通过3个周期
范德比尔特退伍军人研究卓越特别计划(孢子)。我们相信我们的应用程序,在
Toto,大于其各部分的总和,我们期待着与Htan进行强大的双向互动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert J. Coffey其他文献
Studies on uterine collagenase in tissue culture. II. Effect of steroid hormones on enzyme production.
组织培养子宫胶原酶的研究。
- DOI:
- 发表时间:
1971 - 期刊:
- 影响因子:0
- 作者:
John J. Jeffrey;Robert J. Coffey;A. Z. Eisen - 通讯作者:
A. Z. Eisen
Stereotactic drainage of Aspergillus brain abscess with long-term survival: case report and review.
曲霉菌脑脓肿的立体定向引流与长期生存:病例报告和回顾。
- DOI:
- 发表时间:
1989 - 期刊:
- 影响因子:4.8
- 作者:
Michael L. Goodman;Robert J. Coffey - 通讯作者:
Robert J. Coffey
Sa1613 - Expression of Lrig1, a Negative Regulator of Egfr, is Dynamically Altered in Different Stages of Gastric Carcinogenesis
- DOI:
10.1016/s0016-5085(18)31437-9 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Hyunji Kim;Sungsook Yu;Yejin Cho;Robert J. Coffey;James R. Goldenring;Ki Taek Nam;Mijeong Yang;Keunwook Lee;Sang-Ho Jeong;Kyung-Min Lim - 通讯作者:
Kyung-Min Lim
Sa1629 - Testosterone-Dependent Differential Expression of Egfr in Male and Female Mice and Its Implications for Carcinogenesis and Treatment Response
- DOI:
10.1016/s0016-5085(18)31453-7 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Won Jae Huh;Kathleen Rhoades;Robert J. Coffey - 通讯作者:
Robert J. Coffey
126 EGFR SIGNALING IN GASTRIC CHIEF CELL IS NECESSARY FOR THE PATHOGENESIS OF MÉNÉTRIER'S DISEASE VIA NOTCH SIGNALING ACTIVATION
- DOI:
10.1016/s0016-5085(23)01006-5 - 发表时间:
2023-05-01 - 期刊:
- 影响因子:
- 作者:
Tryston T. Gabriel;Robert J. Coffey;Won Jae Huh - 通讯作者:
Won Jae Huh
Robert J. Coffey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert J. Coffey', 18)}}的其他基金
Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation
结直肠肿瘤转化中宿主和微环境的综合单细胞图谱
- 批准号:
10820067 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
Shaping the Microenvironment by DPEP1 Facilitates Adenoma Progression
通过 DPEP1 塑造微环境促进腺瘤进展
- 批准号:
10518847 - 财政年份:2022
- 资助金额:
$ 21.18万 - 项目类别:
Shaping the Microenvironment by DPEP1 Facilitates Adenoma Progression
通过 DPEP1 塑造微环境促进腺瘤进展
- 批准号:
10697369 - 财政年份:2022
- 资助金额:
$ 21.18万 - 项目类别:
Role of WNT-EGFR crosstalk by EVs and exomeres in normal colon and colon cancer
EV 和外泌体 WNT-EGFR 串扰在正常结肠和结肠癌中的作用
- 批准号:
10544807 - 财政年份:2020
- 资助金额:
$ 21.18万 - 项目类别:
Project 1: Interrogating Distinct Tumor-Initiating Cells in CRC
项目 1:研究 CRC 中不同的肿瘤起始细胞
- 批准号:
10700848 - 财政年份:2019
- 资助金额:
$ 21.18万 - 项目类别:
Distribution of Molecular Features for Colorectal Cancers in Northern Tanzania
坦桑尼亚北部结直肠癌的分子特征分布
- 批准号:
10845027 - 财政年份:2019
- 资助金额:
$ 21.18万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
- 批准号:
10657069 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
- 批准号:
23K14614 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
- 批准号:
23K15075 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
- 批准号:
23H02698 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
- 批准号:
10743611 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:














{{item.name}}会员




